MedPath

Investigation of the natural variance of human time experience

Recruiting
Conditions
F84.5
F31
F32
F20
Asperger syndrome
Bipolar affective disorder
Depressive episode
Schizophrenia
Registration Number
DRKS00020493
Lead Sponsor
Forschungszentrum Jülich GmbH Institut für Neurowissenschaften und Medizin (INM-3) Kognitive Neurowissenschaft
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
360
Inclusion Criteria

For healthy subjects:
-Clinical and anamnestic exclusion from neurological and mental disorders.
-No current psychotropic medication.
-Age between 18 and 55 years.
-Normal or corrected vision.
-Legally effective, written consent form of the subject to participation in the study.

For groups with diagnosis F84.5 (ASS):
-Diagnosed with Asperger's-Syndrome (F84.5) according to the ICD-10.
-Clinical and anamnestic exclusion from comorbid neurological and mental disorders.
-No current psychotropic medication.
-Age between 18 and 55 years.
-Normal or corrected vision.
-Legally effective, written consent form of the subject to participation in the study.

For groups with diagnosis F31 or F32 (Depression): -Diagnosed with Depression (F31 or F32) according to the ICD-10.
-Clinical and anamnestic exclusion from comorbid neurological and mental disorders.
-Age between 18 and 55 years.
-Normal or corrected vision.
-Legally effective, written consent form of the subject to participation in the study.

For groups with diagnosis F20 (Schizophrenia). -Diagnosed with Schizophrenia (F20) according to the ICD-10.
-Clinical and anamnestic exclusion from comorbid neurological and mental disorders.
-Age between 18 and 55 years.
-Normal or corrected vision.
-Legally effective, written consent form of the subject to participation in the study.

Exclusion Criteria

Exclusion Criteria for healthy subjects:
-Minors and people older than 55 years.
-Current or preceding diagnosis of a mental or neurological disorder.
-Existent internal ailments (malignant tumors, HIV-infection: no HIV-tests will be carried out.)
-Known MRI- or EEG-abnormalities.
-Acute suicidal tendency, risk of self-harm or harm to others.
-Missing legally effective, written consent form of subjects to participation in the study, people not qualified for legal acts or those in governmental or judicial custody (PsychKG, BTG).

Exclusion Criteria for patients with Asperger's-Syndrome (F84.5):
-Minors and people older than 55 years.
-Current or preceding diagnosis of a mental or neurological disorder, but not F84.5.
-Existent internal ailments (malignant tumors, HIV-infection: no HIV-tests will be carried out.)
-Known MRI- or EEG-abnormalities.
-Acute suicidal tendency, risk of self-harm or harm to others.
-Missing legally effective, written consent form of subjects to participation in the study, people not qualified for legal acts or those in governmental or judicial custody (PsychKG, BTG).

Exclusion Criteria for patients with Depression (F31 & F32):
-Minors and people older than 55 years.
-Current or preceding diagnosis of a mental or neurological disorder, but not F31 or F32.
-Existent internal ailments (malignant tumors, HIV-infection: no HIV-tests will be carried out.)
-Known MRI- or EEG-abnormalities.
-Acute suicidal tendency, risk of self-harm or harm to others.
-Missing legally effective, written consent form of subjects to participation in the study, people not qualified for legal acts or those in governmental or judicial custody (PsychKG, BTG).

Exclusion Criteria for patients with Schizoprenia (F20.x):
-Minors and people older than 55 years.
-Current or preceding diagnosis of a mental or neurological disorder, but not F20.x.
-Existent internal ailments (malignant tumors, HIV-infection: no HIV-tests will be carried out.)
-Known MRI- or EEG-abnormalities.
-Acute suicidal tendency, risk of self-harm or harm to others.
-Missing legally effective, written consent form of subjects to participation in the study, people not qualified for legal acts or those in governmental or judicial custody (PsychKG, BTG).

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Goal is the examination of human time perception (duration and passage of time) and the influence of various environmental factors.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath